Skip to content
healthcare.dev

Meclizine HCL 12.5 mg

NDC 17714-117, Meclizine HCL 12.5 mg, tablet, from Advance Pharmaceutical Inc..

Product NDC
17714-117
Status
Listed
Labeler
Advance Pharmaceutical Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
part336
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17714-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MECLIZINE HYDROCHLORIDE12.5 mg/1

Pharmacologic classes

Antiemetic [EPC]; Emesis Suppression [PE]

Package NDCNDC-11Package
17714-117-0117714011701100 TABLET in 1 BOTTLE (17714-117-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17714-117 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17714-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17714-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.